Anti-PTEN-alpha; clone 3A4.1

Code: MABS1680 D2-231

Not available outside of the UK & Ireland.

Application

Immunohistochemistry Analysis: A 1:1,000 dilution from a representative lot detected PTEN-alpha in human cerebellum, pancreas, and small intestine tissue sections...


 Read more

Your Price
$516.21 EACH

Not available outside of the UK & Ireland.

Application

Immunohistochemistry Analysis: A 1:1,000 dilution from a representative lot detected PTEN-alpha in human cerebellum, pancreas, and small intestine tissue sections.

Detect PTEN-alpha using this mouse monoclonal Anti-PTEN-alpha, clone 3A4.1 Antibody, Cat. No. MABS1680, validated for use in Immunohistochemistry (Paraffin) and Western Blotting.

General description

Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16, EC 3.1.3.48, EC 3.1.3.67; UniProt P60484; also known as Mitochondrial PTENalpha, Phosphatase and tensin-like protein, Mutated in multiple advanced cancers 1, Mitochondrial phosphatase and tensin protein alpha, phosphatase and tensin homolog deleted on chromosome 10) is encoded by the PTEN (also known as 10q23del, BRRS, BZS, CWS1, GLM2, MMAC1, MHAM, TEP1) gene (Gene ID 5728) in human. PTEN is a tumor suppressor that catalyzes the removal of phosphate from phosphoserine, phosphothreonine, and phosphotyrosine residues on substrate proteins, as well as the phosphate in the D3 position of the inositol ring from phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3,4-diphosphate, phosphatidylinositol 3-phosphate and inositol 1,3,4,5-tetrakisphosphate. PTEN plays a major role in controlling cell growth and proliferation, and PTEN gene mutains are found in a large number of cancers at high frequency. PTEN activity, stability, localization, and conformation are controlled through complex regulatory mechanisms, including the reversible phosphorylations of several Ser/Thr (S/T) residues in its unfolded C-terminal tail region (PTEN-Ctail, residues 351 403). Alternative translation start site 519 base pairs upstream of the ATG initiation sequence results in the translational variant of PTEN-alpha (PTEN-Long), including additional 173 N-terminal amino acids to the canonical 403-a.a. PTEN sequence. PTEN-Long is a membrane-permeable phosphatase secreted by PTEN-Long producing cells and can enter other cells as an exogenous PI3K signaling-inhibitory agent. PTEN-Long is reported to induce tumor cell death in vitro and in vivo.

Immunogen

GST-tagged recombinant human PTEN-alpha N-terminal fragment.

Other Notes

Concentration: Please refer to lot specific datasheet.

Physical form

Purified mouse monoclonal antibody IgG2aκ in buffer containing 0.1 M Tris-Glycine (pH 7.4) 150 mM NaCl with 0.05% sodium azide

Format: Purified

Quality

Evaluated by Western Blotting in MCF-7 cell lysate.

Western Blotting Analysis: 0.5 µg/mL of this antibody detected PTEN-alpha in 10 µg of MCF-7 cell lysate.

Specificity

Clone 3A4.1 targets an N-terminal region specific to the spliced isoform alpha (PTEN-Long; P60484-2) and not present in spliced isoform 1 (a.k.a. 55 kDa isoform) or isoform 3.

Target description

~78 kDa observed. 64.88 kDa calculated. Uncharacterized bands may be observed in some lysate(s).

antibody formpurified antibody
antibody product typeprimary antibodies
biological sourcemouse
clone3A4.1, monoclonal
Gene Informationhuman ... PTEN(5728), TEP1(7011)
isotypeIgG2aκ
NCBI accession no.NP_001291646
Quality Level100
shipped inambient
species reactivityhuman
technique(s)western blot: suitable, immunohistochemistry: suitable (paraffin)
UniProt accession no.P60484-2
This product has met the following criteria to qualify for the following awards:



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.